February 2020 FDA Recall Drug by Par Pharmaceutical Inc.
D-0843-2020 - Labeling

This Class III drug recall was voluntarily initiated by Par Pharmaceutical Inc. on February 10, 2020 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0843-2020

Reason for Recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April 2022.
Initiated
02-10-2020
Reported
02-19-2020
Quantity
9,936 cartons

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Par Pharmaceutical Inc.
Nationwide in the USA
Frovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablets per carton, Rx Only, Manufactured by: Almac Pharma Services Limited, Craigavon, BT63 5UA, UK; Manufactured for: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 0603-3718-34.

Batch or Lot Expiration Information

Lot# Lot Number: 9698818; labeled expiration AUG 2022; actual expiration APR 2022